Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jul;22(4):390-6.
doi: 10.1097/MNH.0b013e32836214b9.

Nephrolithiasis and loss of kidney function

Mira T Keddis  1 , Andrew D Rule
Affiliations
Review

Nephrolithiasis and loss of kidney function

Mira T Keddis et al. Curr Opin Nephrol Hypertens. 2013 Jul.

Abstract

Purpose of review: The prevalence of nephrolithiasis has been on the rise over recent decades. There have also been extensive efforts to identify risk factors for chronic kidney disease (CKD). The purpose of this review is to highlight recent evidence on the association of nephrolithiasis with the development of CKD and end-stage renal disease (ESRD).

Recent findings: Several epidemiologic studies over the past decade assessed the relationship between history of nephrolithiasis and CKD. Across several studies, patients with nephrolithiasis had about a two-fold higher risk for decreased renal function or need for renal replacement therapy. This risk appears to be independent of risk factors for CKD that are common in stone formers such as hypertension and diabetes mellitus. Specific risk factors for CKD in stone formers include recurrent urinary tract infections, struvite and possibly uric acid stone composition, symptomatic stones, solitary kidney, ileal conduit, neurogenic bladder, and hydronephrosis.

Summary: Recent evidence has shown a consistent relationship between nephrolithiasis history and an increased risk of CKD and ESRD. Understanding the characteristics that predispose to CKD may better inform how to optimally manage patients with nephrolithiasis and prevent this complication.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

There are no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Forest plot of multivariable adjusted hazard ratios for ESRD risk with nephrolithiasis in various subgroups. Adapted with permission [23▪▪]. ESRD, end-stage renal disease.
FIGURE 2
FIGURE 2
The cumulative ESRD incidence in symptomatic stone formers compared to controls. Adapted with permission [14▪▪]. ESRD, end-stage renal disease.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lotan Y. Economics and cost of care of stone disease. Adv Chronic Kidney Dis. 2009;16:5–10. - PubMed
    1. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States. Kidney Int. 2003;63:1817–1823. - PubMed
    1. Sakhaee K, Maalouf NM, Sinnott B. Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management. J Clin Endocrinol Metab. 2012;97:1847–1860. - PMC - PubMed
    1. Sakhaee K. Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens. 2008;17:304–309. - PubMed
    1. Gaudio KM, Siegel NJ, Hayslett JP, Kashgarian M. Renal perfusion and intratubular pressure during ureteral occlusion in the rat. Am J Physiol. 1980;238:F205–209. - PubMed

Publication types

MeSH terms